Ipratropium bromide dry-powder inhalation - Dura/Spiros
Alternative Names: Ipratropium bromide Spiros; SCH 1000 dry-powder inhalation - Dura/SpirosLatest Information Update: 24 Oct 2021
At a glance
- Originator Dura Pharmaceuticals; Spiros Development Corporation II
- Class Antiasthmatics; Antibronchitics; Atropine derivatives; Bronchodilators; Small molecules
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 07 Jul 2000 New profile
- 07 Jul 2000 Discontinued-Unspecified Phase in Asthma in USA (Inhalation)
- 07 Jul 2000 Discontinued-Unspecified Phase in Chronic obstructive pulmonary disease in USA (Inhalation)